
British Journal of Cancer, Published online: 08 April 2020; doi:10.1038/s41416-020-0817-7
Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma
Medicine RSS-Feeds by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου